Semaglutide
STEP 1
Novo Nordisk · Phase 3 · Completed · Enrollment 1961
Y axis: Change in body weight from baseline, %
X axis: Weeks since randomization
Cited trial source. Only weeks the source states.
- Semaglutide s.c. 2.4 mg once weekly: week 68 -14.9%
- Semaglutide placebo: week 68 -2.4%
One reported week is a point at that week. It is not a line from 0%. A solid line connects two or more reported weeks.